An atypical result from a cervical screening test indicates that some cells collected from the cervix show irregularities. These cellular changes are often linked to infections, inflammation, or precancerous conditions. For example, the presence of Human Papillomavirus (HPV) can lead to such changes, resulting in an irregular outcome.
Identifying these irregularities is crucial for preventing cervical cancer. Early detection allows for timely intervention, significantly reducing the risk of the disease progressing. Screening programs have historically demonstrated a substantial decrease in cervical cancer incidence and mortality rates due to their ability to identify and address these cellular anomalies at an early stage.